Iranian Society of Gynecology Oncology
Epidemiological and pathological factors in breast cancer patients in Tehran-Iran: A Single-Centered, Retrospective Study

Nasrin Ziamajidi; Nazi Moini; Hiva Danesh; Roghayeh Abbasalipourkabir; Nahid Radnia; Zeinab Barartabar

Articles in Press, Accepted Manuscript, Available Online from 05 September 2023

  Background & Objective: Breast cancer has the highest incidence of all cancers and the incidence of this disease is increasing rapidly in many countries around the world, including Iran. In this study, some epidemiological and pathological factors have been investigated in breast cancer patients.Methods: ...  Read More

Gynecology Oncology
Molecular Epidemiology of Breast Cancer in Iran: A Review Article

Roya Dolatkhah; Mehrnaz Hosseinalifam; Zohreh Sanaat; Neda Dolatkhah; Saeed Dastgiri

Volume 8, Issue 5 , September and October 2023, , Pages 426-434

  Breast cancer (BC) was the most common cancer in Iran, accounting for 12.9% of all incident cancer, and was the 5th leading cause of cancer death in 2020. The latest age standardized incidence rate (ASIR) of breast cancer was 35.8 in Iran and is expected to increase to more than 70 per 100,000 by the ...  Read More

Gynecology Oncology
Preserving Fertility and Its Outcomes in Iranian Women with Cancer: A Longitudinal Cohort Study

Batool Hossein Rashidi; Marjan Ghaemi; Ensieh Shahrokh Tehrani; Marzieh Mohebbi; Marzieh Savari

Volume 8, Issue 5 , September and October 2023, , Pages 450-460

  Background & Objective: Preserving fertility in women with cancer before therapeutic interventions is very important. This study was evaluating the 8 years’ experience of an onco-fertility center from 2013 to 2020 on fertility preservation and its outcomes in female cancer survivors.Materials ...  Read More

Gynecology Oncology
Association of breast cancer with human papillomavirus types 16 and 18 in the north of Iran

Fereshteh Fakour; Zahra Rafiei Sorouri; Amirhossein hajizadeh Fallah; Atefeh Mousavi; maral farahmand

Volume 8, Issue 2 , March and April 2023, , Pages 173-180

  Background and objective: In Iranian women, the age of breast cancer is 10-20 years earlier than women living in developed countries. Moreover, HPV infection has increased among Iranian women and it is more common compared to European women. The purpose of the present study is to investigate the role ...  Read More

Gynecology Oncology
Prevalence and Correlates of the Estrogen and Progesterone Receptors (ER/PR), Human Epidermal Growth Factor Receptor-2 (HER-2) and P53 in Breast Cancer: a Cross-Sectional Study

Hakimeh Akbari; Hossein Forouzandeh; Tooraj Reza Mirshekari; Seyed Adnan Kashfi; Mehdi Ghavamizadeh

Volume 7, Issue 6 , September and October 2022, , Pages 507-512

  Background & Objective: Breast cancer has a pivotal role in many deaths caused by malignancies. Epidermal growth factor receptor-2 (EGFR-2 or HER-2) and estrogen receptor (ER) have immense predictive values as prognostic factors. Breast cancers that have steroid receptors and respond to hormone ...  Read More

Gynecology Oncology
The Importance of RTK Signaling Genes and their Inhibitors in Breast Cancer

Maryam Rahimi; Setareh Talebi Kakroodi; Mansoureh Tajvidi

Volume 7, Issue 4 , March and April 2022, , Pages 258-271

  Receptor tyrosine kinase (RTK) signaling is a crucial pathway in the development of many cancers. KIT, PI3K, and AKT are the major genes in this pathway. KIT RTK functions in cell signal transduction in various cell types, such as cancer cells. A central element of RTK signaling is phosphatidylinositol-4, ...  Read More

Gynecology Oncology
Survival Pattern Depending on Hormone Receptor Status, Stages of Breast Cancer and Social-Economic Status- A Cohort Study

Sharon Baisil; Rashmi Kundapur; Sachin Chandramoha; Maria Nelliyanil; Prince Abhraham; Vijith Shetty; Rajesh Ballal

Volume 7, Issue 3 , January and February 2022, , Pages 221-225

  Background and Objective: Breast cancer is the most common cancer among females globally and its toll is rapidly rising in India. Accurate knowledge about prognostic factors could assist oncologists in making correct treatment decisions and acquiring a better understanding of the survival of patients. ...  Read More

General surgery
Comparison of Awareness Level about Breast Cancer Risk Factors, Presentations, and Screening Rules and Tools: A Cross-sectional Study on General Female Population

Atefeh Moridi; Sudabeh Mahmoodi; Nayereh Rahmati; Marzieh Fathi; Zahra Naeiji

Volume 6, Issue 4 , August 2021, , Pages 188-194

  Background & Objective: Awareness of breast cancer risk factors, clinical presentations and screening rules and methods may encourage women to use preventive measures more commonly. Materials & Methods: A total of 691 women from general population were interviewed using a standardized ...  Read More

Gynecology Oncology
The Relation between Exon Variations of KIT Gene and Clinical Pathological Factors of Breast Cancer

Maryam Rahimi; Elahe Keyhani; Farkhondeh Behjati

Volume 5, Issue 4 , December 2020, , Pages 137-148

  Background & Objective: As the most common cancer type, breast cancer has been recognized as the second mortality cause among women. The KIT proto-oncogene is one of the important factors involved in tumor development. The previous findings have demonstrated an increased copy number and overexpression ...  Read More

Joint Frailty Modeling for Multiple Recurrent Events and Its Application in Patients with Breast Cancer

Freshteh Osmani; Ebrahim Hajizadeh; Ali Akbar Rasekhi

Volume 3, Issue 2 , May and June 2018, , Pages 53-58

  Aims: Breast cancer is one of the most prevalent recurrent cancers among women. Several factors affecting multiple recurrences of this disease have been studied and recognized in various studies. One of the various types of models used to analyze recurrent events considering the lack of homogeneity among ...  Read More

Pregnancy-Associated Breast Cancer

Azadeh Joulaee; Nasibeh Khaleghnejad-Tabari

Volume 2, Issue 4 , November and December 2017, , Pages 1-3

  The majority of cases are very young, less than 40 years old, which means they are out of the screening age range. For older pregnant women, screening is not done both due to possible radiation exposure of fetus and low accuracy of mammographyin pregnancy-induced highly dense breasts. Therefore, all ...  Read More